D
Daniel J. Diekema
Researcher at University of Iowa Hospitals and Clinics
Publications - 456
Citations - 36676
Daniel J. Diekema is an academic researcher from University of Iowa Hospitals and Clinics. The author has contributed to research in topics: Broth microdilution & Voriconazole. The author has an hindex of 96, co-authored 440 publications receiving 33922 citations. Previous affiliations of Daniel J. Diekema include Roy J. and Lucille A. Carver College of Medicine & University of Iowa.
Papers
More filters
Journal ArticleDOI
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
TL;DR: Improved non-culture-based diagnostics are needed to expand the potential for preemptive (or early directed) therapy and improve diagnostic, preventive, and therapeutic strategies is necessary to reduce the considerable morbidity and mortality associated with IC.
Journal ArticleDOI
Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999
Daniel J. Diekema,M. A. Pfaller,F. J. Schmitz,J. Smayevsky,Jan M. Bell,R N Jones,Mondell L. Beach +6 more
TL;DR: Given the increasing multidrug resistance among staphylococci and the possible emergence of vancomycin-resistant strains, global strategies are needed to control emergence and spread of multiply resistant staphlyococci.
Journal ArticleDOI
Attributable Mortality of Nosocomial Candidemia, Revisited
Olafur Gudlaugsson,Olafur Gudlaugsson,Shane Gillespie,Kathleen Lee,Jeff Vande Berg,Jianfang Hu,Shawn A. Messer,Loreen A. Herwaldt,Loreen A. Herwaldt,Michael A. Pfaller,Michael A. Pfaller,Daniel J. Diekema,Daniel J. Diekema +12 more
TL;DR: Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.
Journal ArticleDOI
Epidemiology of Invasive Mycoses in North America
TL;DR: The epidemiologic profiles of these invasive mycoses in North America are discussed, as well as risk factors for infection, and the pathogens’ antifungal susceptibility.
Journal ArticleDOI
Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus
M. A. Pfaller,Daniel J. Diekema +1 more
TL;DR: The frequency of invasive mycoses due to opportunistic fungal pathogens has increased significantly over the past two decades ([35][1], [74][2], [83][3], [88][4], [89][5], [101][6], [106][7]).